Low Dose Aspirin in the Prevention of Preeclampsia in China
Status:
Completed
Trial end date:
2019-03-30
Target enrollment:
Participant gender:
Summary
Preeclampsia is one of the three leading causes of maternal morbidity and mortality all over
the world. The use of low dose aspirin has been mentioned in several studies with promising
results. The investigators decided to evaluate the use of low dose aspirin in Chinese
pregnant women, starting between 12+ and 20 weeks of pregnancy, based on clinical
characteristics aiming to reduce the incidence of preeclampsia.